TNSN96074A1 - Sel de pyrrolidinyl-methyl-indole - Google Patents

Sel de pyrrolidinyl-methyl-indole

Info

Publication number
TNSN96074A1
TNSN96074A1 TNTNSN96074A TNSN96074A TNSN96074A1 TN SN96074 A1 TNSN96074 A1 TN SN96074A1 TN TNSN96074 A TNTNSN96074 A TN TNSN96074A TN SN96074 A TNSN96074 A TN SN96074A TN SN96074 A1 TNSN96074 A1 TN SN96074A1
Authority
TN
Tunisia
Prior art keywords
pyrrolidinyl
methyl
indole
indole salt
salt
Prior art date
Application number
TNTNSN96074A
Other languages
English (en)
Inventor
Martin James Wythes
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of TNSN96074A1 publication Critical patent/TNSN96074A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'INVENTION CONCERNE LE SEL D'ACIDE FUMARIQUE DE L'ACIDE (R)-5- (METHYLAMINOSULFONYLMETHYL)-3-(N-METHYLPYRROLIDINE-2-YLMETHYL)-1H- INDOLE , UNE COMPOSITION PHARMACEUTIQUE LE CONTENANT ET SON PROCEDE DE PRODUCTION. CE COMPOSE PEUT ETRE UTILISE EN MEDECINE HUMAINE NOTAMMENT POUR LE TRAITEMENT DE LA MIGRAINE.
TNTNSN96074A 1995-05-20 1996-05-17 Sel de pyrrolidinyl-methyl-indole TNSN96074A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent

Publications (1)

Publication Number Publication Date
TNSN96074A1 true TNSN96074A1 (fr) 2005-03-15

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN96074A TNSN96074A1 (fr) 1995-05-20 1996-05-17 Sel de pyrrolidinyl-methyl-indole

Country Status (42)

Country Link
US (1) US5994387A (fr)
EP (1) EP0827503B1 (fr)
JP (1) JP3233940B2 (fr)
KR (1) KR100295255B1 (fr)
CN (1) CN1063175C (fr)
AP (1) AP738A (fr)
AR (1) AR003949A1 (fr)
AT (1) ATE194986T1 (fr)
AU (1) AU701154B2 (fr)
BG (1) BG63046B1 (fr)
BR (1) BR9610858A (fr)
CA (1) CA2219631C (fr)
CO (1) CO5040221A1 (fr)
CZ (1) CZ287939B6 (fr)
DE (1) DE69609504T2 (fr)
DK (1) DK0827503T3 (fr)
DZ (1) DZ2034A1 (fr)
ES (1) ES2148753T3 (fr)
GB (1) GB9510223D0 (fr)
GR (1) GR3034290T3 (fr)
HK (1) HK1017884A1 (fr)
HR (1) HRP960223B1 (fr)
HU (1) HU217657B (fr)
IL (1) IL118239A (fr)
IS (1) IS1908B (fr)
LV (1) LV11992B (fr)
MA (1) MA23876A1 (fr)
MX (1) MX9708966A (fr)
MY (1) MY132066A (fr)
NO (1) NO312068B1 (fr)
NZ (1) NZ306448A (fr)
OA (1) OA10747A (fr)
PL (1) PL183142B1 (fr)
PT (1) PT827503E (fr)
RU (1) RU2161618C2 (fr)
SK (1) SK281782B6 (fr)
TN (1) TNSN96074A1 (fr)
TR (1) TR199701397T1 (fr)
UA (1) UA44320C2 (fr)
WO (1) WO1996036632A1 (fr)
YU (1) YU29496A (fr)
ZA (1) ZA963938B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
JP2015524400A (ja) * 2012-07-19 2015-08-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ９−［４−（３−クロロ−２−フルオロ−フェニルアミノ）−７−メトキシ−キナゾリン−６−イルオキシ］−１，４−ジアザ−スピロ［５．５］ウンデカン−５−オンのフマル酸塩、その薬物としての使用及び調製

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (fr) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
HUP9801761A3 (en) 1999-06-28
CZ364897A3 (cs) 1998-11-11
NO975210L (no) 1997-11-13
KR19990014934A (ko) 1999-02-25
UA44320C2 (uk) 2002-02-15
CZ287939B6 (cs) 2001-03-14
HRP960223A2 (en) 1997-10-31
NO312068B1 (no) 2002-03-11
NO975210D0 (no) 1997-11-13
DE69609504T2 (de) 2000-12-14
ZA963938B (en) 1997-11-17
SK281782B6 (sk) 2001-07-10
HRP960223B1 (en) 2000-12-31
MY132066A (en) 2007-09-28
LV11992A (lv) 1998-03-20
HUP9801761A2 (hu) 1999-05-28
PL323143A1 (en) 1998-03-16
AP738A (en) 1999-03-23
DK0827503T3 (da) 2000-11-20
BG102053A (en) 1998-06-30
US5994387A (en) 1999-11-30
RU2161618C2 (ru) 2001-01-10
IS1908B (is) 2003-12-31
PL183142B1 (pl) 2002-05-31
JP3233940B2 (ja) 2001-12-04
MA23876A1 (fr) 1996-12-31
GR3034290T3 (en) 2000-12-29
EP0827503B1 (fr) 2000-07-26
HU217657B (hu) 2000-03-28
JPH10506639A (ja) 1998-06-30
AP9600801A0 (en) 1996-04-30
CO5040221A1 (es) 2001-05-29
CN1063175C (zh) 2001-03-14
AU5500596A (en) 1996-11-29
ES2148753T3 (es) 2000-10-16
IL118239A0 (en) 1996-09-12
KR100295255B1 (ko) 2001-08-07
ATE194986T1 (de) 2000-08-15
GB9510223D0 (en) 1995-07-19
HK1017884A1 (en) 1999-12-03
EP0827503A1 (fr) 1998-03-11
LV11992B (en) 1998-06-20
BR9610858A (pt) 1999-07-13
OA10747A (en) 2002-12-11
MX9708966A (es) 1998-03-31
PT827503E (pt) 2000-11-30
CN1185152A (zh) 1998-06-17
TR199701397T1 (xx) 1998-03-21
WO1996036632A1 (fr) 1996-11-21
SK154197A3 (en) 1999-01-11
DE69609504D1 (de) 2000-08-31
IS4605A (is) 1997-10-30
AR003949A1 (es) 1998-09-30
AU701154B2 (en) 1999-01-21
DZ2034A1 (fr) 2002-07-21
YU29496A (sh) 1998-12-23
BG63046B1 (bg) 2001-02-28
IL118239A (en) 2000-10-31
NZ306448A (en) 1998-10-28
CA2219631C (fr) 2001-01-23
CA2219631A1 (fr) 1996-11-21

Similar Documents

Publication Publication Date Title
TNSN98019A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN01009A1 (fr) (+) - 6 - [amino - (6 - chloro - pyridine - 3 - yl) - (3 - methyl - 3h - imidazole - 4 - yl) - methyl ] - 4 - ( 3 - chloro-phenyl) -1- cyclopropylmethyl - 1h - quinoleine - 2 - one, procede pour sa preparation et composition la contenant
TNSN96104A1 (fr) Trihydrate de metahensulfonate de (1s,2s)-1-(4-hydroxyphenyl) -2-(4-hydroxy-4-phenylpiperidine-1-yl)-1-propanol et composition pharmaceutique le contenant
FR2442054A1 (fr) Proteines purifiees, notamment interferon, procede de preparation et compositions pharmaceutiques les contenant
TNSN98022A1 (fr) DERIVES DE N-HYDROXY-β-SULFONYLPROPIONAMIDE, PROCEDE POUR LEUR PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT.
TNSN98025A1 (fr) Derives d'acide arylsulfonylhydroxamique, procede pour leur preparation et compositions les contenant.
TNSN97087A1 (fr) 4(3h)-quinazolinones 2,3-disubstituees nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99053A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydro- pyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
MA23258A1 (fr) Nouvelle formule contenant une nouvelle forme physique d'un sel magnesium d'omeprazole, son procede de fabrication et son utilisation.
TNSN99055A1 (fr) Derives bicycliques d'acide hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99253A1 (fr) Composes chimiques nouveaux modulateurs de ccr5, et compositions pharmaceutiques les contenant.
HUT72970A (en) Risperidone pamoate, pharmaceutical composition containing it and process for their production
TNSN98182A1 (fr) Agonistes de prostaglandines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99156A1 (fr) Derives d'acide hydroxypipecolate-hydroxamique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN00036A1 (fr) Acides oxamiques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98112A1 (fr) Composes dipeptidiques
BE1002406A5 (fr) Compositions pharmaceutiques.
TNSN00231A1 (fr) Forme cristalline de 4-carboxyamino-2-substitue-1,2,3,4- tetrahydroquinoleine, et compositions la contenant
BE900563A (fr) Composition pharmaceutique pour le traitement d'etats d'insuffisance renale aigue.
TNSN99214A1 (fr) Azalides nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN98113A1 (fr) Procede de preparation de composes utiles pour le traitement de la resistance a l'insuline.
TNSN98127A1 (fr) Derives d'azetidinylpropylpiperidine , procede pour leur preparation et compositions pharmaceutiques les contenant.
BE1002415A4 (fr) 1-(4-aminophenyl)-4-methyl-7,8-methylenedioxy-3,4-dihydro-5h-2,3-benzodiazepine, ses sels d'addition acides et procede pour les preparer.
TNSN01046A1 (fr) Ethers de diphenyle utiles en therapeutique
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant